From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: arguing with Steve O'Hara, as we miss out on Darren the Leatherman and Lucian the cowboy

By Tom Winnifrith | Friday 1 July 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I apologise for ShareProphets's lack of Pride celebrations, unlike the big corporates. Next year. Or maybe not. Then, it is on to my argument with Steve O'Hara at Optibiotix (OPTI). I do not regret buying more shares, but I am, nevertheless, cross. I explain this, before looking at Dev Clever (DEV) and something very fishy indeed. After that, I discuss Ben's Creek (BEN), the Adam Wilson CV and why this will all end in tears. Finally, an IPO: Alteration Earth (ALTE), and why you should avoid it like the plague.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 08:54:05